PubRank

D A Drachman

Author PubWeight™ 75.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med 1992 5.93
2 Statins and the risk of dementia. Lancet 2000 5.65
3 Occam's razor, geriatric syndromes, and the dizzy patient. Ann Intern Med 2000 4.72
4 An approach to the dizzy patient. Neurology 1972 3.06
5 Who may drive? Who may not? Who shall decide? Ann Neurol 1988 2.28
6 Human memory and the cholinergic system. A relationship to aging? Arch Neurol 1974 2.24
7 Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis. J Neurol Neurosurg Psychiatry 2001 1.91
8 Ophthalmoplegia plus. The neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol 1968 1.79
9 Letter: Extrapyramidal dementia and levodopa. Lancet 1975 1.60
10 Synaptic loss in Alzheimer's disease and other dementias. Neurology 1989 1.57
11 Memory and the hippocampal complex. II. Is memory a multiple process? Arch Neurol 1966 1.42
12 Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Arch Neurol 1995 1.38
13 Expression of heat shock proteins in Alzheimer's disease. Neurology 1991 1.35
14 Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 1977 1.34
15 Experimental denervation of ocular muscles. A critique of the concept of "ocular myopathy". Arch Neurol 1969 1.32
16 Incontinence and troublesome behaviors predict institutionalization in dementia. J Geriatr Psychiatry Neurol 1992 1.24
17 Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin Genet 2007 1.16
18 The remote myopathy of trichinosis. Neurology 1965 1.12
19 Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology 1996 1.10
20 Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity. J Am Geriatr Soc 1988 1.09
21 Primary progressive aphasia with focal neuronal achromasia. Neurology 1991 1.04
22 Familial Alzheimer's disease: site of mutation influences clinical phenotype. Ann Neurol 2000 1.03
23 Vacuolar change in Alzheimer's disease. Arch Neurol 1987 1.01
24 Histocompatibility (HL-A) factors in familial multiple sclerosis. Is multiple sclerosis susceptibility inherited via the HL-A chromosome? Arch Neurol 1976 0.95
25 Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol 2001 0.93
26 Immunosuppression and the Guillain-Barré syndrome. Arch Neurol 1970 0.90
27 Thalamic dementia and motor neuron disease. Neurology 1989 0.90
28 Aging, memory, and the cholinergic system: a study of dichotic listening. Neurobiol Aging 1980 0.89
29 If we live long enough, will we all be demented? Neurology 1994 0.89
30 Active and passive P3 latency and psychometric performance: influence of age and individual differences. Int J Psychophysiol 1992 0.89
31 Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging 1992 0.89
32 See-saw nystagmus. J Neurol Neurosurg Psychiatry 1966 0.87
33 Marker proteins of platelet activation in patients with cerebrovascular disease. Arch Neurol 1982 0.86
34 Dizziness, epilepsy and the EEG. Dis Nerv Syst 1977 0.85
35 Propranolol, hallucinations, and sleep disturbance. Am J Psychiatry 1982 0.83
36 Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies. J Neurol Neurosurg Psychiatry 1975 0.83
37 Posturally-evoked vomiting; Association with posterior fossa lesions. Ann Otol Rhinol Laryngol 1977 0.83
38 Memory decline in the aged: treatment with lecithin and physostigmine. Neurology 1982 0.83
39 New criteria for the diagnosis of vascular dementia: do we know enough yet? Neurology 1993 0.82
40 Neuropsychological features of familial Alzheimer's disease. Ann Neurol 1992 0.81
41 Memory and cognitive function in the elderly. A preliminary trial of physostigmine. Arch Neurol 1980 0.80
42 Memory and the hippocampal complexes. 3. Aging and temporal EEG abnormalities. Neurology 1971 0.80
43 Procainamide---a hazard in myasthenia gravis. Arch Neurol 1965 0.80
44 Bell's palsy. A neurological point of view. Arch Otolaryngol 1969 0.80
45 Electrical source analysis of auditory ERPs in medial temporal lobe amnestic syndrome. Electroencephalogr Clin Neurophysiol 1993 0.79
46 Rate of progression in familial Alzheimer's disease. J Geriatr Psychiatry Neurol 1996 0.79
47 Treatment of Alzheimer's disease -- searching for a breakthrough, settling for less. N Engl J Med 1997 0.79
48 Psychological features in persons at risk for familial Alzheimer's disease. Am J Alzheimers Dis Other Demen 2001 0.79
49 Motor neuron disease and paraproteinemia. Neurology 1987 0.78
50 Immunosuppression and the Guillain-Barré syndrome. Neurology 1970 0.78
51 Alzheimer's disease: what is it, how many people have it, and why do we need to know? Neurology 2000 0.78
52 Hand muscle atrophy in multiple sclerosis. Arch Neurol 1983 0.77
53 Vascular amyloid deposition in Alzheimer's disease. Neither necessary nor sufficient for the local formation of plaques or tangles. Arch Neurol 1993 0.77
54 ERP indices and neuropsychological performance as predictors of functional outcome in dementia. J Geriatr Psychiatry Neurol 1995 0.76
55 Memory impairment in the aged: storage versus retrieval deficit. J Exp Psychol 1972 0.76
56 The indusium griseum: is it involved in Alzheimer's disease? Neurobiol Aging 1990 0.76
57 Risk factors for seizure-related motor vehicle crashes in patients with epilepsy. Neurology 1999 0.75
58 Antimicrobial prophylaxis after tick bites. N Engl J Med 1993 0.75
59 First report of the congressionally appointed Advisory Panel on Alzheimer's Disease. J Gerontol 1990 0.75
60 Role of the dorsomedial nucleus of the thalamus in Alzheimer's disease. J Geriatr Psychiatry Neurol 1995 0.75
61 Multidimensional Assessment of Dementia: a means of revealing distinctive clinical patterns. Trans Am Neurol Assoc 1981 0.75
62 From capitation to rhinocitation. Int J Dermatol 1998 0.75
63 Aging, memory and the hippocampal complex. Neurology 1968 0.75
64 Pain of neurologic interest. Am J Phys Med 1967 0.75
65 Tumor-associated aphasia in left hemisphere primary brain tumors: the importance of age and tumor grade. Neurology 1989 0.75
66 Getting the best return on the employee benefit dollar. Health Prog 1988 0.75
67 The relationship of MMPI subtype membership to demographic variables and treatment outcome among substance misusers. J Stud Alcohol 1983 0.75
68 Status epilepticus and Epstein-Barr virus encephalopathy. Diagnosis by modern serologic techniques. Arch Neurol 1985 0.75
69 A community marketing survey of a proposed ambulatory care facility. J Health Care Mark 1983 0.75
70 Cholinergic enhancement and REM sleep latency in the aged: lecithin does not reproduce physostigmine effect. Neurology 1986 0.75
71 Complaint-oriented clinics. JAMA 1973 0.75
72 The "memory cliff" beyond span in immediate recall. Psychol Rep 1967 0.75
73 Myocardial infarction, seizure and an abnormal head CT scan. Postgrad Med J 1999 0.75
74 Dizziness and disorders of equilibrium--panel 8. Arch Neurol 1979 0.75
75 Aging, memory, and the cholinergic system: a study of dichotic listening. Trans Am Neurol Assoc 1979 0.75
76 Bladder smooth muscle excitability and response properties. Invest Urol 1969 0.75
77 Disorders of tone. Am J Phys Med 1967 0.75
78 Caretaker Obstreperous Behavior Rating Scale. Int Psychogeriatr 1996 0.75
79 Measuring dementia: assessment of multiple deficit domains. J Clin Psychol 1988 0.75
80 The senile patient. GP 1967 0.75